These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4271453)

  • 1. [Antibodies against poliomyelitis in children of Comayagua Valley, Honduras].
    Cáceres LM; Figueroa M; Tróchez H
    Bol Oficina Sanit Panam; 1973 Nov; 75(5):424-9. PubMed ID: 4271453
    [No Abstract]   [Full Text] [Related]  

  • 2. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 3. [Poliomyelitis antibody determination 10 years after vaccination with inactivated Salk virus vaccine].
    Hofman B
    Ned Tijdschr Geneeskd; 1971 Jul; 115(27):1148-51. PubMed ID: 5580506
    [No Abstract]   [Full Text] [Related]  

  • 4. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mali children antipoliomyelitic immunity before and after two oral immunizations against poliomyelitis (author's transl)].
    Fofana Y; Ehrengut W; Koch I; Allerdist H; Diallo D
    Med Trop (Mars); 1981; 41(2):151-5. PubMed ID: 7242300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killed polio virus vaccine in the control of poliomyelitis in Finland.
    Lapinleimu K
    Ann Clin Res; 1982 Dec; 14(5-6):199-203. PubMed ID: 6303196
    [No Abstract]   [Full Text] [Related]  

  • 7. [IgM-specific neutralizing antibodies against poliovirus in cases of poliomyelitis].
    Salmerón García F
    Bol Oficina Sanit Panam; 1982 Mar; 92(3):203-7. PubMed ID: 6279126
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.
    Trivello R; Farisano G; Bonello C; Moschen ME; Baldo V; Majori S; Moretti G; Marin V; Piron L; Renzulli G
    Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 10. [History and results of a campaign against poliomyelitis].
    Rotta C; Fiandaca S
    Minerva Med; 1967 Aug; 58(61):2755-9. PubMed ID: 6049069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status of herd immunity to poliomyelitis in children in the Moscow region].
    Seĭbil' VB; Voroshilova MK; Boĭko VM; Troshina LD
    Vopr Virusol; 1975; (1):87-91. PubMed ID: 123674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Revaccination of school children with a live vaccine against poliomyelitis].
    Koza J; Matyásová I; Skovránek V; Danes L; Losová M
    Cesk Pediatr; 1983 Apr; 38(4):207-11. PubMed ID: 6303606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of neutralizing antibodies against polioviruses in vaccinated children.
    Shukla I; Malik A; Bal A; Ansari Z
    Indian Pediatr; 1982 Jun; 19(6):493-7. PubMed ID: 6292090
    [No Abstract]   [Full Text] [Related]  

  • 15. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward wild poliovirus eradication in El Salvador, Guatemala, and Honduras.
    Bull Pan Am Health Organ; 1987; 21(4):439-43. PubMed ID: 3440181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Poliomyelitis control program in Brasil: study of immunity levels].
    Bastos NC; De Carvalho Filho ES; Schatzmayr H; Homma A; Chaves J
    Bol Oficina Sanit Panam; 1973 Dec; 75(6):511-22. PubMed ID: 4273161
    [No Abstract]   [Full Text] [Related]  

  • 18. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS
    Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
    Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
    Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.